Cargando…

Design and Development of Tools for Risk Evaluation of Diabetes and Cardiovascular Disease in Community Pharmacy

There is an increasing motivation to implement pharmacist-led screening services in community pharmacies. This study aims to develop tools to support the pharmacist in the context of a diabetes and cardiovascular disease risk assessment service. Our development involved a multistep process using a u...

Descripción completa

Detalles Bibliográficos
Autores principales: Rondeaux, Sarah, Braeckman, Tessa, Beckwé, Mieke, El Oueriaghli El Ghammaz, Dounia, Devroey, Dirk, De Vriese, Carine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9956138/
https://www.ncbi.nlm.nih.gov/pubmed/36833517
http://dx.doi.org/10.3390/ijerph20042819
_version_ 1784894519005675520
author Rondeaux, Sarah
Braeckman, Tessa
Beckwé, Mieke
El Oueriaghli El Ghammaz, Dounia
Devroey, Dirk
De Vriese, Carine
author_facet Rondeaux, Sarah
Braeckman, Tessa
Beckwé, Mieke
El Oueriaghli El Ghammaz, Dounia
Devroey, Dirk
De Vriese, Carine
author_sort Rondeaux, Sarah
collection PubMed
description There is an increasing motivation to implement pharmacist-led screening services in community pharmacies. This study aims to develop tools to support the pharmacist in the context of a diabetes and cardiovascular disease risk assessment service. Our development involved a multistep process using a user-centred approach, including a need assessment phase (14 patients, 17 pharmacists) and a creative design phase, followed by the evaluation of the materials (10 patients, 16 pharmacists). Three following themes covering educational needs emerged from stakeholders’ discussions: “content”, “layout”, and “form”, with three additional themes regarding the practical organisation: “software”, “awareness”, and “referral”. Based on the need assessment, tools for patient education purposes and awareness campaigns were created. During the development, special attention was paid to the writing style and structure with less text and more graphical colourful elements to suit patients with different health literacy and educational levels. The evaluation phase allowed researchers to observe participants engaging with the materials. Overall, participants were satisfied with the tools. The contents were considered valuable and relevant. However, adaptations were necessary to ensure their understanding and long-term usability. Finally, future research is required to evaluate the materials’ impact on patients’ behaviour towards their identified risk factors and ensure their effectiveness.
format Online
Article
Text
id pubmed-9956138
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99561382023-02-25 Design and Development of Tools for Risk Evaluation of Diabetes and Cardiovascular Disease in Community Pharmacy Rondeaux, Sarah Braeckman, Tessa Beckwé, Mieke El Oueriaghli El Ghammaz, Dounia Devroey, Dirk De Vriese, Carine Int J Environ Res Public Health Article There is an increasing motivation to implement pharmacist-led screening services in community pharmacies. This study aims to develop tools to support the pharmacist in the context of a diabetes and cardiovascular disease risk assessment service. Our development involved a multistep process using a user-centred approach, including a need assessment phase (14 patients, 17 pharmacists) and a creative design phase, followed by the evaluation of the materials (10 patients, 16 pharmacists). Three following themes covering educational needs emerged from stakeholders’ discussions: “content”, “layout”, and “form”, with three additional themes regarding the practical organisation: “software”, “awareness”, and “referral”. Based on the need assessment, tools for patient education purposes and awareness campaigns were created. During the development, special attention was paid to the writing style and structure with less text and more graphical colourful elements to suit patients with different health literacy and educational levels. The evaluation phase allowed researchers to observe participants engaging with the materials. Overall, participants were satisfied with the tools. The contents were considered valuable and relevant. However, adaptations were necessary to ensure their understanding and long-term usability. Finally, future research is required to evaluate the materials’ impact on patients’ behaviour towards their identified risk factors and ensure their effectiveness. MDPI 2023-02-05 /pmc/articles/PMC9956138/ /pubmed/36833517 http://dx.doi.org/10.3390/ijerph20042819 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Rondeaux, Sarah
Braeckman, Tessa
Beckwé, Mieke
El Oueriaghli El Ghammaz, Dounia
Devroey, Dirk
De Vriese, Carine
Design and Development of Tools for Risk Evaluation of Diabetes and Cardiovascular Disease in Community Pharmacy
title Design and Development of Tools for Risk Evaluation of Diabetes and Cardiovascular Disease in Community Pharmacy
title_full Design and Development of Tools for Risk Evaluation of Diabetes and Cardiovascular Disease in Community Pharmacy
title_fullStr Design and Development of Tools for Risk Evaluation of Diabetes and Cardiovascular Disease in Community Pharmacy
title_full_unstemmed Design and Development of Tools for Risk Evaluation of Diabetes and Cardiovascular Disease in Community Pharmacy
title_short Design and Development of Tools for Risk Evaluation of Diabetes and Cardiovascular Disease in Community Pharmacy
title_sort design and development of tools for risk evaluation of diabetes and cardiovascular disease in community pharmacy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9956138/
https://www.ncbi.nlm.nih.gov/pubmed/36833517
http://dx.doi.org/10.3390/ijerph20042819
work_keys_str_mv AT rondeauxsarah designanddevelopmentoftoolsforriskevaluationofdiabetesandcardiovasculardiseaseincommunitypharmacy
AT braeckmantessa designanddevelopmentoftoolsforriskevaluationofdiabetesandcardiovasculardiseaseincommunitypharmacy
AT beckwemieke designanddevelopmentoftoolsforriskevaluationofdiabetesandcardiovasculardiseaseincommunitypharmacy
AT eloueriaghlielghammazdounia designanddevelopmentoftoolsforriskevaluationofdiabetesandcardiovasculardiseaseincommunitypharmacy
AT devroeydirk designanddevelopmentoftoolsforriskevaluationofdiabetesandcardiovasculardiseaseincommunitypharmacy
AT devriesecarine designanddevelopmentoftoolsforriskevaluationofdiabetesandcardiovasculardiseaseincommunitypharmacy